AJG Quote, Financials, Valuation and Earnings

CorVel has a net margin of 11.14% compared to Arthur J. Gallagher &'s net margin of 10.43%. Arthur J. Gallagher &'s return on equity of 10.38% beat CorVel's return on equity of 32.6%.

Arthur J. Gallagher & has a consensus price target of $297.14, signalling upside risk potential of 4.96%. On the other hand CorVel has an analysts' consensus of -- which suggests that it could fall by --. Given that Arthur J. Gallagher & has higher upside potential than CorVel, analysts believe Arthur J. Gallagher & is more attractive than CorVel.

Arthur J. Gallagher & has a beta of 0.740, which suggesting that the stock is 26.032% less volatile than S&P 500. In comparison CorVel has a beta of 1.139, suggesting its more volatile than the S&P 500 by 13.888%.

Arthur J. Gallagher & has a quarterly dividend of $0.60 per share corresponding to a yield of 0.85%. CorVel offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arthur J. Gallagher & pays 48.85% of its earnings as a dividend. CorVel pays out -- of its earnings as a dividend. Arthur J. Gallagher &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $2.8B, which are larger than CorVel quarterly revenues of $224.4M. Arthur J. Gallagher &'s net income of $312.6M is higher than CorVel's net income of $23.4M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 53.92x while CorVel's PE ratio is 73.24x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 5.59x versus 7.07x for CorVel. Usually stocks with elevated PS ratios are considered overvalued.

eHealth has a net margin of 11.14% compared to Arthur J. Gallagher &'s net margin of -72.72%. Arthur J. Gallagher &'s return on equity of 10.38% beat eHealth's return on equity of -5.64%.

Arthur J. Gallagher & has a consensus price target of $297.14, signalling upside risk potential of 4.96%. On the other hand eHealth has an analysts' consensus of $7.38 which suggests that it could fall by -11.25%. Given that Arthur J. Gallagher & has higher upside potential than eHealth, analysts believe Arthur J. Gallagher & is more attractive than eHealth.

Arthur J. Gallagher & has a beta of 0.740, which suggesting that the stock is 26.032% less volatile than S&P 500. In comparison eHealth has a beta of 0.473, suggesting its less volatile than the S&P 500 by 52.725%.

Arthur J. Gallagher & has a quarterly dividend of $0.60 per share corresponding to a yield of 0.85%. eHealth offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arthur J. Gallagher & pays 48.85% of its earnings as a dividend. eHealth pays out -12.52% of its earnings as a dividend. Arthur J. Gallagher &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $2.8B, which are larger than eHealth quarterly revenues of $58.4M. Arthur J. Gallagher &'s net income of $312.6M is higher than eHealth's net income of -$42.5M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 53.92x while eHealth's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 5.59x versus 0.52x for eHealth. Usually stocks with elevated PS ratios are considered overvalued.

Kingstone Companies has a net margin of 11.14% compared to Arthur J. Gallagher &'s net margin of 17.12%. Arthur J. Gallagher &'s return on equity of 10.38% beat Kingstone Companies's return on equity of 40.22%.

Arthur J. Gallagher & has a consensus price target of $297.14, signalling upside risk potential of 4.96%. On the other hand Kingstone Companies has an analysts' consensus of -- which suggests that it could fall by -4.06%. Given that Arthur J. Gallagher & has higher upside potential than Kingstone Companies, analysts believe Arthur J. Gallagher & is more attractive than Kingstone Companies.

Arthur J. Gallagher & has a beta of 0.740, which suggesting that the stock is 26.032% less volatile than S&P 500. In comparison Kingstone Companies has a beta of 0.712, suggesting its less volatile than the S&P 500 by 28.819%.

Arthur J. Gallagher & has a quarterly dividend of $0.60 per share corresponding to a yield of 0.85%. Kingstone Companies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Arthur J. Gallagher & pays 48.85% of its earnings as a dividend. Kingstone Companies pays out -- of its earnings as a dividend. Arthur J. Gallagher &'s payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $2.8B, which are larger than Kingstone Companies quarterly revenues of $40.8M. Arthur J. Gallagher &'s net income of $312.6M is higher than Kingstone Companies's net income of $7M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 53.92x while Kingstone Companies's PE ratio is 13.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 5.59x versus 1.40x for Kingstone Companies. Usually stocks with elevated PS ratios are considered overvalued.

Marsh & McLennan Companies has a net margin of 11.14% compared to Arthur J. Gallagher &'s net margin of 13.11%. Arthur J. Gallagher &'s return on equity of 10.38% beat Marsh & McLennan Companies's return on equity of 31.46%.

Arthur J. Gallagher & has a consensus price target of $297.14, signalling upside risk potential of 4.96%. On the other hand Marsh & McLennan Companies has an analysts' consensus of $232.03 which suggests that it could grow by 9.58%. Given that Marsh & McLennan Companies has higher upside potential than Arthur J. Gallagher &, analysts believe Marsh & McLennan Companies is more attractive than Arthur J. Gallagher &.

Arthur J. Gallagher & has a beta of 0.740, which suggesting that the stock is 26.032% less volatile than S&P 500. In comparison Marsh & McLennan Companies has a beta of 0.943, suggesting its less volatile than the S&P 500 by 5.724%.

Arthur J. Gallagher & has a quarterly dividend of $0.60 per share corresponding to a yield of 0.85%. Marsh & McLennan Companies offers a yield of 1.44% to investors and pays a quarterly dividend of $0.82 per share. Arthur J. Gallagher & pays 48.85% of its earnings as a dividend. Marsh & McLennan Companies pays out 34.56% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

Arthur J. Gallagher & quarterly revenues are $2.8B, which are smaller than Marsh & McLennan Companies quarterly revenues of $5.7B. Arthur J. Gallagher &'s net income of $312.6M is lower than Marsh & McLennan Companies's net income of $747M. Notably, Arthur J. Gallagher &'s price-to-earnings ratio is 53.92x while Marsh & McLennan Companies's PE ratio is 26.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Arthur J. Gallagher & is 5.59x versus 4.39x for Marsh & McLennan Companies. Usually stocks with elevated PS ratios are considered overvalued.